Brahmachary Enugurthi

Title: Brahmachary Enugurthi: Innovator in GLP-1 Receptor Modulation

Introduction

Brahmachary Enugurthi is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate the glucagon-like peptide 1 (GLP-1) receptor. His work has implications for various therapeutic applications, especially in the treatment of metabolic disorders.

Latest Patents

Enugurthi holds 1 patent for his innovative work on GLP-1 receptor modulators. The patent details compounds that modulate the GLP-1 receptor, along with products containing such compounds and methods for their use and synthesis. The compounds are characterized by a specific structure, as outlined in Formula (I), which includes pharmaceutically acceptable salts.

Career Highlights

Brahmachary Enugurthi is currently associated with Receptos, Inc., where he continues to advance research in the field of receptor modulation. His expertise and innovative approach have positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Enugurthi has collaborated with notable colleagues, including Junko Tamiya and Philip Turnbull, to further enhance the research and development of GLP-1 receptor modulators.

Conclusion

Brahmachary Enugurthi's contributions to the field of pharmacology through his patent on GLP-1 receptor modulators highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic options in treating metabolic disorders.